Baidu
map

MedSci:2015年十五大**医疗科技盘点

2015-12-25 MedSci MedSci原创

2015年中,在医疗保健领域诞生了很多让人眼前一亮的高科技产品。下面,MedSci就来盘点一下2015年十五大最顶尖的医疗科技技术。 DEKA 卢克手臂系统 DEKA卢克手臂系统医疗器械,可以接收患者残肢处肌肉收缩的电活动信号,并将这些电信号传输到假肢中的计算机处理器,处理器会将信号进一步转化为肢体活动,让残障人士也可以轻松地做出喝水、吃饭、拿东西等各种日常生活中的动作,比起现有的普通

2015年中,在医疗保健领域诞生了很多让人眼前一亮的高科技产品。下面,MedSci就来盘点一下2015年十五大最顶尖的医疗科技技术。

DEKA 卢克手臂系统

DEKA卢克手臂系统医疗器械,可以接收患者残肢处肌肉收缩的电活动信号,并将这些电信号传输到假肢中的计算机处理器,处理器会将信号进一步转化为肢体活动,让残障人士也可以轻松地做出喝水、吃饭、拿东西等各种日常生活中的动作,比起现有的普通义肢拥有更大的操控性能,而且尺寸和重量基本上和成人的手臂一样,可以说,科幻电影里出现的半机械人的时代即将到来。

Organovo 3D打印人体组织

2015年4月1日3D生物打印技术公司Organovo在波士顿的实验生物学会议上公布了世界上第一个3D生物打印全细胞肾组织的数据。这样一来医药公司生产的每一种药都可以在类似肝脏、肾脏的条件下测试效果。在药物对人体应用之前,这个是最好的也是最终的药物测试系统。

预防下一场流行病:VSV-EBOV埃博拉疫苗

一种新的疫苗常常需要6~10年来完成临床试验,而埃博拉病毒的疫苗仅仅花了10个月。2014年8月,当人们意识到它在西非的爆发是全球性的健康危机时,世界卫生组织就加快疫苗的研究过程。这种疫苗通过将埃博拉病毒的蛋白质转移到其他病毒上来,以引发一种防止埃博拉发病的免疫反应。为了测试它的效果,几内亚的医疗工作者在100例已确认的埃博拉患者上使用了“环形战略(ring strategy)”。首先,医生对大约4000个最近接触过埃博拉感染者的成人注射了疫苗,接受注射之后他们都没有患上埃博拉。在另一组实验中,医生给3500个3周前确认感染的人注射了疫苗,其中只有16人发病。“环形战略”的核心是给所有接触过感染者的人注射疫苗,这样就相当于建造了一面防火墙,阻止了病毒的传播。”世界卫生组织的健康系统和创新部门的副主任,研究与开发部的领导人Marie-Paule Kieny说。这次埃博拉疫苗的研发证明了科学家可以很快地完成药物的研发并将其投入应用。今后,这样可以防止其他疾病威胁全球。



精确用药的指南:人类表观基因组图


June的研究标志了第一张人类表观基因组图的发表:化学标志可以告诉人们DNA将要表达的性状以及何时表达。“若把基因组比作电脑的硬件,那么表观基因组就是软件。”学院基因组分析室的主任Joseph Ecker说。这么一张地图有助于科学家弄清楚是什么使有些细胞分化成了肝脏细胞,有些细胞分化成了心脏细胞,有些则变成了恶性肿瘤。明白这其中的原理后,科学家们能够以生物工程技术对基因重组,或是发现新的诱发疾病的因素。


粘在皮肤上的健康监测器:“生物邮票(BioStamp)”


可穿戴设备常常是笨重的。然而“生物邮票”却是一个小巧便捷的设备:它是一个可以在皮肤上粘上一周的电子玩意,就像一个临时纹身一样。嵌在一张邮票大小的粘性胶纸中的传感器和线路能测量体温、运动、肌肉活动、心率和紫外线照射度。这个设备之后可将这些检测数据通过蓝牙发送到穿戴者或是医生的手机上。目前用于测量血压和出汗的“生物邮票”还在研发中。


“大脑检查”灯:FITGuard


头盔不再只是运动员用于防止脑震荡或其他脑伤害的装备了。如同护口器一样的FITGuard中的传感器,能测量运动员头部的线性加速度和角加速度,并可将这些数据发送到场外教练的手机或平板电脑上。当某位运动员受到猛烈冲击时,LED灯就会亮起,表示这位运动员是否需要退场休息。在场外,其他相关的应用程序会对运动员进行光敏感性检测和记忆缺失测试,帮助医生确定这位运动员受脑震荡的可能性。它的售价是100美元。

美敦力Micra Transcatheter 起搏系统

心脏起搏器大都是通过手术植入在胸腔中,起搏器通过电线连接心脏。而现在,只有药片大小的Micra起搏器可以通过一根导管,通过股静脉进入心脏。它的末端就可以附在心脏上直接向其传导电脉冲。它的电池寿命高达10年以上。而且当电池耗尽时,医生可以将它关闭并在附近安装新的起搏器。

隐形助听器Eargo

法国耳鼻喉外科医生弗洛伦特·米歇尔设计的隐形助听器Eargo,具有由硅胶纤维制成的翅膀,能使助听器悬停在耳道外部,使人几乎感受不到助听器的存在。这种创新设计不仅保证声音的有效传播,还可增加耳道透气性,佩戴舒适度极高。

一次完成放疗的Xoft体系

乳腺癌病人的放疗疗程需要8周,且几乎需要天天去医院接受放疗。而现在,一种叫做手术中放疗的方法只需不到12分钟:在肿瘤切除手术中,放射医师只需给予病人一次集中辐射剂量。这样的放疗是为了杀死手术中残留的恶性肿瘤细胞,有助于防止癌症复发。最近完成的二项的临床试验发现,它和传统的放疗一样有显著的疗效。而且这种新的疗法可以使病人少受副作用折磨,使生活更快地回归正常。

美敦力混合闭环体系

糖尿病患者们必须时刻监测自己的血糖并注射胰岛素来弥补其胰岛功能的不足。美敦力研发了一个新的系统,无论白天或者晚上,它都能自动给予患者适量的胰岛素。这样,患者们就不用再费心地计算算他们所需要的剂量,不用担忧人为因素导致的用药错误。

新抗生素Teixobactin

Teixobactin可以消灭耐药菌株,比如结核分枝杆菌——结核病的元凶。和其他抗生素不同,Teixobactin可以在两个靶区域和细菌结合,细菌难以对它产生耐药性。这种药物仍然在生产当中,并且它只对几种细菌有效,其中的一种细菌是侵袭性耐甲氧西林金黄色葡萄球菌,每年有成千上万人受到它的感染。

XStat快速止血系统

如果患者严重出血,无论是在战场上,还是急救车上,仅仅靠纱布和外部压力是远远不够的。美国公司RevMedx研发的Xstat是一种新型止血海棉注射器, 可以将含有抗菌凝血剂凝和消炎作用的覆膜海棉注入几英寸深的伤口,15秒之内就能有效止血,比传统的塞纱布或伤口加压更有效。

放射成像设备

荷兰乌得勒支大学医学中心正在打造一个实验室,同时引进两台设备:Elekta直线加速器和1.5 Tesla MRI磁共振成像仪。这两种设备的组合前所未有,由于成像和治疗能同时进行,希望能够提供更准确的肿瘤治疗。 此外,通用电气(GE)还将推出3.0 T MRI,成像时间做多可缩短2/3。新设备还采用了GE最新的SilentScan,设备在工作时将更加安静。西门子也展示了新的SOMATOM Definition Edge CT扫描仪,使用单源X射线管进行双能量成像。

荧光药丸摄像头可精确扫描肿瘤


药丸摄像头近年来发展越来越成熟,在医疗领域的应用广泛。相比传统的内窥镜来说,病人在接受检查的过程中会减少很多痛苦。但目前的药丸摄像头多数使用普通的小型光源来照明,极大限制了它们进入人体后的成像精度。

英国格拉斯哥大学研究人员开发出一种微型荧光成像设备,体积足够小,可以放进药丸中通过吞服进入人体。有了荧光的特性,医护人员就能看到更多普通可见光下不明显的体内供血变化,这类变化与肿瘤生长有着重要关系。

研究人员说,这种摄像头虽然微小,但拥有足够的能量对人体整个胃肠道开展长达14小时的成像扫描。

领导这项研究的格拉斯哥大学教授戴维·卡明说,这项技术还需要进一步研发才能完全成熟并实用化。他们也希望未来能将这种技术运用到其他领域,比如超声波检查等。

可分离血液中癌细胞的生物芯片问世


澳大利亚新南威尔士大学的一个科研团队研发的这种生物芯片,在一个名为“癌症透析”的设备中过滤血液,甄别并移除癌细胞。该团队研发这种芯片的初衷,是想寻找一种较便宜且痛苦较少的癌症诊断方法。

团队负责人马吉德·瓦尔基阿尼博士称,人类癌症中99%的癌症是实体瘤,而进入人体外周血(除骨髓之外的血液)循环的癌细胞会随着血液转移,扩散到身体其他部位。根据癌细胞比健康细胞大,代谢较旺盛的特点,医生将混有健康细胞和癌细胞的血液放入生物芯片中,在液体压力的影响下,较大的癌细胞和较小的健康细胞分别进入不同的出口,成功分离。

该芯片还能大幅降低与癌症相关的治疗成本。据了解,澳大利亚进行肿瘤检测的扫描费约700澳元(约合3229元人民币),而用这种芯片检测血液中癌细胞的成本仅为50到100澳元(约合230元至460元人民币)。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (15)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    赞!!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    赞!!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    嗯,总结得很好,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    嗯,总结得很好,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    嗯,不错,

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    嗯,不错,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    good

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2016-01-13 medsic

    good

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2015-12-27 1de0837dm52(暂无匿称)

    学习啦

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=56682, encodeId=625256682e2, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56683, encodeId=5d135668321, content=赞!!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 11:00:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56675, encodeId=2237566e5a0, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56676, encodeId=437f566e6c1, content=嗯,总结得很好,, beContent=null, objectType=article, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56677, encodeId=559d566e70d, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56678, encodeId=8fcd566e89c, content=嗯,不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56679, encodeId=03ae566e9b2, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56680, encodeId=d02a566802c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Wed Jan 13 10:59:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49464, encodeId=b52e49464cd, content=学习啦, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=95791668951, createdName=1de0837dm52(暂无匿称), createdTime=Sun Dec 27 18:27:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1536840, encodeId=f896153684025, content=<a href='/topic/show?id=85dc3511216' target=_blank style='color:#2F92EE;'>#医疗科技#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35112, encryptionId=85dc3511216, topicName=医疗科技)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=512412728529, createdName=mnda, createdTime=Sun Dec 27 14:33:00 CST 2015, time=2015-12-27, status=1, ipAttribution=)]
    2015-12-27 mnda

相关资讯

公立医疗系统没钱时,第一个牺牲谁的利益?看看NHS!

英国NHS医院人手短缺是大家众所周知的事情。为了缓解压力,医院会雇用临时工(Agency worker or Temporary worker)解决劳动力不够的问题。本周周一的时候,为了减少临时工的薪水开销,英国出台了新政:分别为临床和非临床工作人员薪水划了封顶线,不同的工作班次不能超过某个上限,此后一段时间,临时工的薪水还会继续减少。目的希望在3年内,节约10亿英镑开支。截止到2016年4月,英

国务院法制办公室关于公布《医疗纠纷预防与处理条例(2015年初送审稿)》公开征求意见的通知

说明: 红色部分是标注重点需要注意的,蓝色部分的是小M的提醒,不是本公开征求意见的内容,请大家注意分辨。如果有 意见,请及时按下面提交意见方式向主管部门提交!维护自身的权益。 国务院法制办公室关于公布《医疗纠纷预防与处理条例(送审稿)》公开征求意见的通知 为进一步维护正常医疗秩序,建立和谐医患关系,卫生计生委起草了《医疗纠纷预防与处理条例(送审稿)》(以下简称送审稿),报送国务院。

颠覆传统医疗模式,微医集团领衔全国首家互联网医院,落户乌镇

伴随“十三五”规划建议落地,健康中国正式升级至“国家战略”,以三医联动、医药分开、分级诊疗为核心的健康中国建设将成为“十三五”期间深化医疗卫生体制改革的重头戏。而“互联网+”将成为深化医改,推进健康中国建设的重要技术手段。 为缓解“看病难、看病贵”问题,党中央、国务院均在重要会议和文件中明确提出了构建分级诊疗就医格局和发挥互联网在医疗改革中的作用。习总书记2015年4月1日在中央深改领导小组举行

九张图读懂台湾“医养结合”

台湾龙潭敏盛医院院长邱献章介绍了台湾医养结合的经验和做法。 日前,以“加强交流合作,共促老年健康”为主题的京台老年健康服务论坛在北京举办。台湾龙潭敏盛医院院长邱献章在进行主题演讲的时候,介绍了台湾医养结合的经验和做法。 与内地相同,恶性肿瘤已经排在了十大死因之首。 在台湾,需要照顾的失能老人数量也在显著增加 台湾的医养结合医疗机构属于整合性医疗与养老照护平台,是将疾病治疗、失能照顾、疾病防

时占祥:机器人在医疗应用上的现状和发展前景

12月12日,在中欧国际工商学院主办的2015中国健康产业创新平台奇璞峰会上,全球医生组织北京代表处负责人时占祥就《机器人在医疗应用上的现状和发展前景》发表了演讲,认为多个观点具启发性,特根据演讲实录整理如下,难免谬误,仅供学习参考。 机器人是在解决人类社会生产力问题 最近两年关于机器人的讨论非常热烈,其中一个比较激烈的观点是人工智能或者机器人是人类在自掘坟墓,这方面,霍金多次强调了类似的

支付宝未来医院:现实打败理想?

2014年5月底,支付宝推出“未来医院计划”,希望通过移动技术和大数据,推动未来的卫生医疗面貌的改变。今年6月,阿里巴巴集团旗下支付宝发布《未来医院一周年服务数据报告》,称“未来医院上线1年,平均每2天就有一家医院加入”,通过“未来医院”服务,用户就医逗留时间缩短了一半,好评率达八成以上。事实果真如此吗? 大医院看病难是老生常谈的话题,过去一年,伴随着“未来医院”的移动就诊服务普及,“看病难”问

Baidu
map
Baidu
map
Baidu
map